Glycorex Transplantation AB - Class B

NEW
NGM:GTAB B (Sweden)   Class B
kr 2.14 +0.28 (+14.75%) Apr 10
At Loss
P/B:
4.77
Market Cap:
kr 168.75M ($ 17.22M)
Enterprise V:
kr 168.98M ($ 17.24M)
Volume:
476.11K
Avg Vol (2M):
48.88K
Warning! GuruFocus detected 1 Severe warning sign with GTAB B. Try a 7-Day Free Trial to check it out.
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
476.11K
Market Cap kr:
168.75M
Market Cap $:
17.22M
At Loss
Avg Vol (2M):
48.88K
Enterprise Value kr:
168.98M
Enterprise Value $:
17.24M
PB Ratio:
4.77
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Glycorex Transplantation AB

ISIN : SE0000524530
http://www.glycorex.se
Solvegatan 41, Lund, SWE, 223 70

Share Class Description:

NGM:GTAB B: Class B
Compare
Compare
OSTO:MVIROSTO:KANOSTO:ALZCUROSTO:GUARDOSTO:NICAOSTO:ATORXOSTO:ACTIXSAT:BIOWKSOSTO:NXTCLOSTO:ELICVRTXASX:CSLREGNXKRX:207940XBRU:ARGXALNYXBRU:UCBONCXKRX:068270BNTX
Traded in other countries / regions
GTAB B.SwedenO33.Germany
IPO Date
1999-12-28
Description
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt 0.97
Equity-to-Asset 0.66
Debt-to-Equity 0.21
Debt-to-EBITDA -6.23
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.74
Distress
Grey
Safe
Beneish M-Score -3.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

4/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 7.6
3-Year EBITDA Growth Rate 31.7
3-Year EPS without NRI Growth Rate 4.1
3-Year Book Growth Rate -26.4

Momentum Rank

3/10
Name Current Vs Industry Vs History
5-Day RSI 71.59
9-Day RSI 59.58
14-Day RSI 52.29
3-1 Month Momentum % -47
6-1 Month Momentum % 22.54
12-1 Month Momentum % 161.73

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.3
Quick Ratio 0.97
Cash Ratio 0.48
Days Inventory 303.03
Days Sales Outstanding 66.57
Days Payable 80.84

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 2.32

Profitability Rank

4/10
Name Current Vs Industry Vs History
Gross Margin % 80.28
Operating Margin % -29.7
Net Margin % -31.12
FCF Margin % 0.29
ROE % -28.63
ROA % -18.82
ROIC % -20.69
3-Year ROIIC % -8.12
ROC (Joel Greenblatt) % -60.43
ROCE % -23.94
Years of Profitability over Past 10-Year 3

GF Value Rank

9/10
Name Current Vs Industry Vs History
PS Ratio 4.5
PB Ratio 4.77
Price-to-Tangible-Book 11.26
Price-to-Free-Cash-Flow 2140
Price-to-Operating-Cash-Flow 2140
EV-to-EBIT -16.19
EV-to-EBITDA -150.73
EV-to-Revenue 4.81
EV-to-FCF 1458.34
Price-to-GF-Value 0.73
Price-to-Projected-FCF 16.46
Price-to-Median-PS-Value 0.74
Price-to-Net-Current-Asset-Value 107
Earnings Yield (Greenblatt) % -6.18
FCF Yield % 0.06

Financials (Next Earnings Date:2025-05-23 Est.)

NGM:GTAB B's 30-Y Financials
AAPL
Income Statement Breakdown FY
Not Enough Data
AAPL
Balance Sheet Breakdown
Not Enough Data
AAPL
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Glycorex Transplantation AB Executives

Details

GF Value: kr2.92

NGM:GTAB B

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 35.159
EPS (TTM) (kr) -0.15
Beta 0.49
3-Year Sharpe Ratio -0.2
3-Year Sortino Ratio -0.34
Volatility % 108.28
14-Day RSI 52.29
14-Day ATR (kr) 0.243303
20-Day SMA (kr) 1.99875
12-1 Month Momentum % 161.73
52-Week Range (kr) 0.75 - 4.4
Shares Outstanding (Mil) 78.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Glycorex Transplantation AB Filings

Filing Date Document Date Form
No Filing Data

Glycorex Transplantation AB Stock Events

Financials Calendars
Event Date Price (kr)
No Event Data

Glycorex Transplantation AB Frequently Asked Questions

What is Glycorex Transplantation AB(NGM:GTAB B)'s stock price today?
The current price of NGM:GTAB B is kr2.14. The 52 week high of NGM:GTAB B is kr4.40 and 52 week low is kr0.75.
When is next earnings date of Glycorex Transplantation AB(NGM:GTAB B)?
The next earnings date of Glycorex Transplantation AB(NGM:GTAB B) is 2025-05-23 Est..
Does Glycorex Transplantation AB(NGM:GTAB B) pay dividends? If so, how much?
Glycorex Transplantation AB(NGM:GTAB B) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.